King’s Health Partners Bladder Cancer Biobank

Bladder cancer (BC) is the 9th most common cancer worldwide, but little progress has been made in improving patient outcomes over the last 25 years. The King’s Health Partners (KHP) BC biobank was established to study unanswered, clinically relevant BC research questions.

Donors are recruited from the Urology or Oncology departments of Guy’s Hospital (UK) and can be approached for consent at any point during their treatment pathway.

Fig. 2

Data and tissue repository available in KHP Bladder Cancer biobank

The King’s Health Partners BC Biobank has assembled a rich data and tissue repository that is clinically and demographically representative of the local South East London BC population, making it a valuable resource for future BC research.

Click here to read more.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.